Growth Metrics

Standard Biotools (LAB) Cash & Current Investments (2010 - 2026)

Standard Biotools (LAB) reported Cash & Current Investments of $455.2 million for Q1 2026, up 74.63% year-over-year from $260.7 million in Q1 2025, and up 142.66% on a QoQ basis from $187.6 million in Q4 2025.

Standard Biotools (LAB) has 17 years of Cash & Current Investments data on file, last reported at $455.2 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 74.63% year-over-year to $455.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $455.2 million (up 74.63% YoY) and the FY2025 annual result came in at $187.6 million, down 36.41% from the prior year.
  • Cash & Current Investments rose to $455.2 million in Q1 2026 per LAB's latest filing, from $187.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $463.6 million in Q1 2024 and bottomed at $31.0 million in Q1 2022.
  • The 5-year median for Cash & Current Investments is $194.9 million (2025), against an average of $235.1 million.
  • The widest annual swing landed in 2022, when Cash & Current Investments jumped 565.73%; it then tumbled 46.98% in 2025.
  • Tracing LAB's Cash & Current Investments over 5 years: stood at $166.8 million in 2022, then plunged by 30.64% to $115.7 million in 2023, then soared by 154.96% to $295.0 million in 2024, then tumbled by 36.41% to $187.6 million in 2025, then surged by 142.66% to $455.2 million in 2026.
  • Per Business Quant, the three latest LAB Cash & Current Investments figures stand at $455.2 million (Q1 2026), $187.6 million (Q4 2025), and $194.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.30 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.38 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 3.67 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.12 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.29 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 439.60 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn 455.18 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 455.18 Mn
Dec 31, 2025 187.58 Mn
Sep 30, 2025 194.90 Mn
Jun 30, 2025 237.09 Mn
Mar 31, 2025 260.65 Mn
Dec 31, 2024 294.96 Mn
Sep 30, 2024 367.62 Mn
Jun 30, 2024 396.00 Mn
Mar 31, 2024 463.57 Mn
Dec 31, 2023 115.69 Mn
Sep 30, 2023 129.65 Mn
Jun 30, 2023 143.10 Mn
Mar 31, 2023 155.33 Mn
Dec 31, 2022 166.80 Mn
Sep 30, 2022 186.18 Mn
Jun 30, 2022 212.23 Mn
Mar 31, 2022 31.00 Mn
Dec 31, 2021 29.47 Mn
Sep 30, 2021 30.33 Mn
Jun 30, 2021 31.88 Mn
Mar 31, 2021 50.76 Mn
Dec 31, 2020 69.54 Mn
Sep 30, 2020 73.36 Mn
Jun 30, 2020 46.47 Mn
Mar 31, 2020 49.56 Mn
Dec 31, 2019 60.71 Mn
Sep 30, 2019 64.84 Mn
Jun 30, 2019 70.94 Mn
Mar 31, 2019 75.13 Mn
Dec 31, 2018 95.40 Mn
Sep 30, 2018 35.83 Mn
Jun 30, 2018 40.42 Mn
Mar 31, 2018 47.27 Mn
Dec 31, 2017 63.14 Mn
Sep 30, 2017 62.37 Mn
Jun 30, 2017 42.03 Mn
Mar 31, 2017 50.28 Mn
Dec 31, 2016 59.43 Mn
Sep 30, 2016 71.25 Mn
Jun 30, 2016 86.41 Mn
Mar 31, 2016 95.22 Mn
Dec 31, 2015 94.97 Mn
Sep 30, 2015 97.07 Mn
Jun 30, 2015 99.93 Mn
Mar 31, 2015 116.41 Mn
Dec 31, 2014 115.30 Mn
Sep 30, 2014 95.26 Mn
Jun 30, 2014 94.74 Mn
Mar 31, 2014 143.15 Mn
Dec 31, 2013 84.34 Mn
Sep 30, 2013 63.68 Mn
Jun 30, 2013 60.43 Mn
Mar 31, 2013 79.57 Mn
Dec 31, 2012 80.01 Mn
Sep 30, 2012 86.16 Mn
Jun 30, 2012 37.87 Mn
Mar 31, 2012 38.88 Mn
Dec 31, 2011 53.47 Mn
Sep 30, 2011 58.93 Mn
Jun 30, 2011 64.35 Mn
Mar 31, 2011 55.83 Mn
Dec 31, 2010 5.72 Mn
Sep 30, 2010 5.08 Mn
Jun 30, 2010 8.07 Mn